NCT03729700

Brief Summary

The investigator hypothesizes that regular consumption of almonds will 1) improve the facial wrinkle severity in post-menopausal women, 2) improve the evenness of facial skin pigmentation, 3) diversify the gut microbiome and increase the short chain fatty acids in the blood, and 4) improve the skin barrier biophysical properties.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 22, 2018

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

October 30, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 5, 2018

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2021

Completed
Last Updated

July 7, 2021

Status Verified

July 1, 2021

Enrollment Period

2.6 years

First QC Date

October 30, 2018

Last Update Submit

July 6, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in wrinkle severity

    Photographs will be obtained at baseline, 8 weeks, 16 weeks, and 24 weeks. The images will be obtained with the 3D Clarity Pro® Facial Modeling and Analysis System (Brigh-Tex BioPhotonics, San Jose, CA) that has standardized positioning and lighting and iPad. The investigator has already validated this measurement tool against standard clinical grading of facial wrinkles.

    24 weeks

Secondary Outcomes (5)

  • Change in facial pigmentation

    24 weeks

  • Change in appearance of facial wrinkles on lateral canthi

    24 weeks

  • Change in facial sebum production

    24 weeks

  • Change in the serum profile

    24 weeks

  • Change in sebum lipid profile

    24 weeks

Study Arms (2)

Almond supplementation

EXPERIMENTAL

The almond dose will be provided as 20% of total energy (20% E) in the diet. This dose was selected based on a previous randomized trial examining lipid parameters in response to 0, 10%, and 20% E as dietary almonds and a recent meta-analysis of intervention trials.

Other: Almond

Control snack

NO INTERVENTION

The control snack will be a typical western diet snack. The calorie-matched control snack will be commercially available individually wrapped food products.

Interventions

AlmondOTHER

The almond dose will be provided as 20% of total energy (20% E) in the diet.

Almond supplementation

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPost-menopausal women
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal women
  • Fitzpatrick skin types 1 and 2
  • Able to follow dietary intervention and attend all study visits

You may not qualify if:

  • Those with a nut allergy
  • Current smokers, those that have smoked within the past year, and former smokers with greater than a 20 pack-year history of smoking, as smoking is a independent risk factor and serves as a confounder for the development of facial wrinkles
  • Those with an autoimmune photosensitive condition or a known genetic condition with a deficiency in collagen production (such as Ehler-Danlos), as this can be a confounder for the development of facial wrinkles
  • Those that already obtain 20% of their energy intake from nut consumption
  • Those with implausible reported energy intakes of \<1,000 kcal/d or \>3,000 kcal/d
  • Individuals who are unwilling to discontinue vitamin E containing supplements and food sources during the washout and intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UC Davis Department of Dermatology, Clinical Trials Unit

Sacramento, California, 95816, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2018

First Posted

November 5, 2018

Study Start

October 22, 2018

Primary Completion

June 1, 2021

Study Completion

June 22, 2021

Last Updated

July 7, 2021

Record last verified: 2021-07

Locations